麻豆传媒

Dr. Christina Li received her medical degree from the Columbia College of Physicians and Surgeons. She completed her residency in general surgery at the University of Maryland and was also a research fellow at the Maryland Center for Videoscopic Surgery. She completed a fellowship in minimally invasive and bariatric surgery at the University of Pennsylvania. She has been performing bariatric surgery for LifeBridge Health since 2004 and is a founding member of Sinai Hospital's Bariatric Center for Excellence. 

Steven K. Libutti, MD, FACS, was appointed as Director of Rutgers Cancer Institute of New Jersey and Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences in January 2017. In addition to his leadership roles within Rutgers University, Dr. Libutti also serves as Senior Vice President of Oncology Services for RWJBarnabas Health, further strengthening the university鈥檚 partnership with the healthcare system. He is also a Professor of Surgery at Rutgers Robert Wood Johnson Medical School and an Affiliated Distinguished Professor in Genetics at the Rutgers School of Arts and Sciences Department of Genetics.

Most recently, Dr. Libutti served as Director for the Montefiore Einstein Center for Cancer Care in New York City and was a Professor and Vice Chairman of the Department of Surgery and Professor in the Department of Genetics at Albert Einstein College of Medicine and Montefiore Health System. A surgical oncologist, Dr. Libutti is an internationally known expert in endocrine surgery and the management of neuroendocrine tumors. He is the immediate Past President of the American Association of Endocrine Surgeons. His clinical practice focuses on gastrointestinal malignancies including cancers of the liver and pancreas.

The recipient of funding from the National Cancer Institute (NCI) for the past 20 years, Dr. Libutti is also a researcher whose work focuses on developing novel cancer therapies through an understanding of the tumor microenvironment and blood vessel formation in tumors. He is studying tumor neovascular formation and the interaction between tumor cells, endothelial cells and the components of the tumor microenvironment including fibroblasts and cancer stem cells. His work also focuses on a better understanding of the tumor suppressor genes MEN1 and FILIP1L.

After graduating magna cum laude from Harvard College, Dr. Libutti received his medical degree from the College of Physicians and Surgeons of Columbia University. He remained at Presbyterian Hospital in New York where he completed his residency in surgery, followed by a fellowship at the NCI in surgical oncology and endocrine surgery. He continued at the NCI where he became a tenured Senior Investigator and Chief of the Tumor Angiogenesis Section in the Surgery Branch.  He has published over 280 peer reviewed journal articles, is Editor-in-Chief of the Nature Journal Cancer Gene Therapy, and holds seven U.S. patents. 

Clinical Expertise:
Neuroendocrine tumors, thyroid cancer, parathyroid tumors, pancreatic cancer, liver cancer, gastrointestinal (GI) cancers, minimally invasive surgery, and clinical trials.

, is a gynecologic oncologist who specializes in the surgical management of female reproductive system cancers, including ovarian, uterine, cervical, vulvar and vaginal cancer. His expertise includes diagnostic and therapeutic procedures, including minimally invasive surgery, chemotherapy and novel drugs.
Eskander is also experienced in clinical trial development and aims to provide individuals with access to innovative medicines during their treatment. He is a member of  and the clinical trials office director for oncology.
As an assistant professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at University of California San Diego, Eskander instructs medical students, residents and fellows. His research focuses on immunotherapy, targeted therapies for treating clear cell and endometrioid ovarian cancer, quality of life in cancer patients, and end-of-life care.
Eskander speaks Arabic and Spanish fluently.

, is a board-certified urologist who specializes in detecting, treating and preventing genitourinary cancer. He is experienced in surgical and nonsurgical treatments for all urologic malignancies, including adrenal, upper tract, renal, bladder, prostate, penile and testicular cancers. He also has expertise in minimally invasive approaches to urologic surgery.
As an associate professor in the Department of Urology, Bagrodia trains medical students, residents and fellows at University of California San Diego School of Medicine, where he leads the genitourinary disease team. He has focused his clinical and research interests on understanding molecular attributes of germ cell tumors, which cause testicular cancer, with the goal of ultimately improving treatments and clinical care. He also has been actively involved in understanding and overcoming societal and epidemiological barriers to optimal care in testicular cancer patients.
Bagrodia, , has been involved in clinical trials for patients with testicular cancer and has conducted extensive research in urologic oncology, primarily in biomarker profiles and molecular signatures of urologic tumors as predictors of clinical outcomes. He has been funded through intramural research grants and also via competitive grants from the Cancer Prevention and Research Institute of Texas (CPRIT) and the National Institutes of Health.
He is the principal author or co-author of more than 150 articles in peer-reviewed publications such as Journal of Clinical Oncology, Nature Genetics, European Urology, Journal of Urology, Urologic Oncology, and Urology. Dr. Bagrodia is also a reviewer for many of these publications, as well as for the British Journal of Urology, Journal of Clinical Pathology and the Annals of Surgical Oncology. He also has contributed to several textbooks.
He also speaks Hindi.

Eric Strauch, MD has particiluar interests in pediatric surgical oncology, minimally invasive surgery, congenital anomalies, and hernias.  He will take care of any patient with any surgical problem both large and small.
Dr. Strauch completed his undergraduate degree at the Johns Hopkins University.  He received his medical degree from the University of Maryland School of Medicine as well as his gerneral surgery training at the University of Maryland.  He completed his traind in pediatric surger  at the Johns Hopkins/University of Maryland combined training program.  
Dr. Strauch has beend named a Top Doctor in the specialty of General Pediatric Surgery by Baltimore Magazine  from 2012-2022.
Medical School:



University of Maryland School of Medicine, 1988



Internship:



University of Maryland Medical Center, 1989



Residency:



University of Maryland Medical Center, 1994



Fellowship:



Johns Hopkins Hospital - PEDIATRIC SURGERY, 1996